Gold Nanoparticles for Drug Delivery: Synthesis Strategies, Functionalization, Therapeutic Applications, and Future Perspectives

Gold nanoparticles (AuNPs) have emerged as promising nanocarriers for advanced drug delivery because of their distinctive physicochemical properties, tunable size and morphology, high surface-to-volume ratio, excellent surface chemistry, and unique optical characteristics. Their surfaces can be readily modified with polymers, biomolecules, targeting ligands, and therapeutic agents, enabling the development of multifunctional delivery systems with improved drug solubility, stability, cellular uptake, and controlled release. Various synthesis approaches, including chemical reduction, seed-mediated growth, green synthesis, photochemical reduction, and physical methods, have been developed to produce AuNPs with controlled dimensions, shapes, and surface characteristics. Among these, chemical reduction remains widely employed because of its simplicity and reproducibility, whereas green synthesis has attracted increasing interest as an environmentally friendly alternative using plant extracts, microorganisms, and naturally occurring biomolecules. Following synthesis, AuNPs can be functionalized using thiol chemistry, polymer coating, electrostatic interactions, and covalent conjugation to facilitate drug encapsulation or attachment. These engineered nanocarriers have demonstrated potential in cancer chemotherapy, antimicrobial treatment, gene delivery, and combination therapy. Furthermore, stimuli-responsive AuNP systems can facilitate localized drug release in response to pH, temperature, light, and other biological or external stimuli. Despite substantial progress, challenges related to long-term toxicity, biodistribution, immune responses, biodegradation, manufacturing reproducibility, and clinical translation remain. This review provides a comprehensive overview of AuNP synthesis strategies, surface engineering, drug-loading mechanisms, and therapeutic applications, while discussing the major limitations and future opportunities for developing safe, effective, and clinically translatable gold-based nanomedicines.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24333285
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gold Nanoparticles for Drug Delivery: Synthesis Strategies, Functionalization, Therapeutic Applications, and Future Perspectives

Weikaixin Kong, Hao Sun, Yuanyin Teng, Xinling Li et al.
1 links
Zenodo (CERN European Organization for Nuclear Research)
Nanoparticle-Based Drug Delivery
article

Gold Nanoparticles for Drug Delivery: Synthesis Strategies, Functionalization, Therapeutic Applications, and Future Perspectives

Weikaixin Kong, Hao Sun, Yuanyin Teng, Xinling Li, Keyang Xu, Weichu Tang
article en

Abstract

Gold nanoparticles (AuNPs) have emerged as promising nanocarriers for advanced drug delivery because of their distinctive physicochemical properties, tunable size and morphology, high surface-to-volume ratio, excellent surface chemistry, and unique optical characteristics. Their surfaces can be readily modified with polymers, biomolecules, targeting ligands, and therapeutic agents, enabling the development of multifunctional delivery systems with improved drug solubility, stability, cellular uptake, and controlled release. Various synthesis approaches, including chemical reduction, seed-mediated growth, green synthesis, photochemical reduction, and physical methods, have been developed to produce AuNPs with controlled dimensions, shapes, and surface characteristics. Among these, chemical reduction remains widely employed because of its simplicity and reproducibility, whereas green synthesis has attracted increasing interest as an environmentally friendly alternative using plant extracts, microorganisms, and naturally occurring biomolecules. Following synthesis, AuNPs can be functionalized using thiol chemistry, polymer coating, electrostatic interactions, and covalent conjugation to facilitate drug encapsulation or attachment. These engineered nanocarriers have demonstrated potential in cancer chemotherapy, antimicrobial treatment, gene delivery, and combination therapy. Furthermore, stimuli-responsive AuNP systems can facilitate localized drug release in response to pH, temperature, light, and other biological or external stimuli. Despite substantial progress, challenges related to long-term toxicity, biodistribution, immune responses, biodegradation, manufacturing reproducibility, and clinical translation remain. This review provides a comprehensive overview of AuNP synthesis strategies, surface engineering, drug-loading mechanisms, and therapeutic applications, while discussing the major limitations and future opportunities for developing safe, effective, and clinically translatable gold-based nanomedicines.

Zenodo (CERN European Organization for Nuclear Research)
Macau University of Science and Technology (MO), Georgia Institute of Technology (US), Emory University (US), King's College London (GB), The Wallace H. Coulter Department of Biomedical Engineering (US), King's College School (GB), University College London (GB), Zhejiang University (CN), Aalto University (FI)
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon